National Centre for Pharmacoeconomics

National Centre for
Pharmacoeconomics

NCPE Ireland

Diclofenac 140mg Medicated Plaster (Itami®) is licensed for the local symptomatic and short-term treatment (max. 7 days) of pain in acute strains, sprains or bruises of the extremities following blunt trauma e.g. sports injuries in adolescents aged from 16 years and adults.

 

NCPE Assessment Process Complete
Rapid review commissioned 31/12/2018
Rapid review completed 17/01/2019
Rapid Review outcome A full HTA is not recommended. The NCPE recommends that diclofenac 140mg Medicated Plaster (Itami®) not be considered for reimbursement.  This recommendation should be considered while also having regard to the criteria specified in the Health (Pricing and Supply of Medical Goods Act) 2013.